These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
713 related items for PubMed ID: 11849248
1. Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. Amato G, Mazziotti G, Rotondi M, Iorio S, Doga M, Sorvillo F, Manganella G, Di Salle F, Giustina A, Carella C. Clin Endocrinol (Oxf); 2002 Jan; 56(1):65-71. PubMed ID: 11849248 [Abstract] [Full Text] [Related]
2. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly. Colao A, Pivonello R, Cappabianca P, Briganti F, Tortora F, Auriemma RS, De Martino MC, Marzullo P, Lombardi G. Clin Endocrinol (Oxf); 2005 Sep; 63(3):342-9. PubMed ID: 16117824 [Abstract] [Full Text] [Related]
9. Long-acting octreotide LAR compared with lanreotide SR in the treatment of acromegaly. Kendall-Taylor P, Miller M, Gebbie J, Turner S, al-Maskari M. Pituitary; 2000 Oct; 3(2):61-5. PubMed ID: 11141697 [Abstract] [Full Text] [Related]
10. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue? Jallad RS, Musolino NR, Kodaira S, Cescato VA, Bronstein MD. Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503 [Abstract] [Full Text] [Related]
11. A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. Murray RD, Melmed S. J Clin Endocrinol Metab; 2008 Aug; 93(8):2957-68. PubMed ID: 18477663 [Abstract] [Full Text] [Related]
12. Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide. Morange I, De Boisvilliers F, Chanson P, Lucas B, DeWailly D, Catus F, Thomas F, Jaquet P. J Clin Endocrinol Metab; 1994 Jul; 79(1):145-51. PubMed ID: 8027218 [Abstract] [Full Text] [Related]
13. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: effect on tumour volume and predictive factors of significant tumour shrinkage. Lucas T, Astorga R, Catalá M, Spanish Multicentre Lanreotide Study Group on Acromegaly. Clin Endocrinol (Oxf); 2003 Apr; 58(4):471-81. PubMed ID: 12641631 [Abstract] [Full Text] [Related]
14. The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly. Colao A, Auriemma RS, Pivonello R. Pituitary; 2016 Apr; 19(2):210-21. PubMed ID: 26290466 [Abstract] [Full Text] [Related]
15. Octreotide as primary therapy for acromegaly. Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL. J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397 [Abstract] [Full Text] [Related]
16. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution. Jallad RS, Musolino NR, Salgado LR, Bronstein MD. Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910 [Abstract] [Full Text] [Related]
17. Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide. Caron P, Morange-Ramos I, Cogne M, Jaquet P. J Clin Endocrinol Metab; 1997 Jan; 82(1):18-22. PubMed ID: 8989225 [Abstract] [Full Text] [Related]
18. The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly. Karavitaki N, Botusan I, Radian S, Coculescu M, Turner HE, Wass JA. Clin Endocrinol (Oxf); 2005 Mar; 62(3):282-8. PubMed ID: 15730408 [Abstract] [Full Text] [Related]
19. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G, Cozzi R. J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832 [Abstract] [Full Text] [Related]